263 related articles for article (PubMed ID: 31692250)
21. Herpes zoster in patients with systemic lupus erythematosus.
Moutsopoulos HM; Gallagher JD; Decker JL; Steinberg AD
Arthritis Rheum; 1978; 21(7):798-802. PubMed ID: 697950
[TBL] [Abstract][Full Text] [Related]
22. Herpes zoster vaccination in SLE: a pilot study of immunogenicity.
Guthridge JM; Cogman A; Merrill JT; Macwana S; Bean KM; Powe T; Roberts V; James JA; Chakravarty EF
J Rheumatol; 2013 Nov; 40(11):1875-80. PubMed ID: 24037550
[TBL] [Abstract][Full Text] [Related]
23. Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications.
Feldman CH; Marty FM; Winkelmayer WC; Guan H; Franklin JM; Solomon DH; Costenbader KH; Kim SC
Arthritis Rheumatol; 2017 Feb; 69(2):387-397. PubMed ID: 27589220
[TBL] [Abstract][Full Text] [Related]
24. Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort.
González-Echavarri C; Capdevila O; Espinosa G; Suárez S; Marín-Ballvé A; González-León R; Rodríguez-Carballeira M; Fonseca-Aizpuru E; Pinilla B; Pallarés L; Ruiz-Irastorza G;
Lupus; 2018 Dec; 27(14):2253-2261. PubMed ID: 30451641
[TBL] [Abstract][Full Text] [Related]
25. Herpes zoster in SLE: prevalence, incidence and risk factors.
Kwan A; Rayes HA; Lazova T; Anderson N; Bonilla D; Su J; Touma Z
Lupus Sci Med; 2022 Jan; 9(1):. PubMed ID: 35017186
[TBL] [Abstract][Full Text] [Related]
26. Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort.
Chen HH; Chen YM; Chen TJ; Lan JL; Lin CH; Chen DY
Clinics (Sao Paulo); 2011; 66(7):1177-82. PubMed ID: 21876970
[TBL] [Abstract][Full Text] [Related]
27. Herpes Zoster Infections in SLE in a University Hospital in Saudi Arabia: Risk Factors and Outcomes.
Sayeeda A; Al Arfaj H; Khalil N; Al Arfaj AS
Autoimmune Dis; 2010 Sep; 2011():174891. PubMed ID: 21152215
[TBL] [Abstract][Full Text] [Related]
28. [Herpes zoster in connective tissue diseases: I. Association with systemic lupus erythematosus and its immunological abnormalities].
Yamauchi Y; Nagasawa K; Tada Y; Tsukamoto H; Yoshizawa S; Mayumi T; Niho Y; Kusaba T
Kansenshogaku Zasshi; 1991 Jul; 65(7):851-6. PubMed ID: 1655920
[TBL] [Abstract][Full Text] [Related]
29. Ovarian function is preserved in women with severe systemic lupus erythematosus after a 6-month course of cyclophosphamide followed by mycophenolate mofetil.
Laskari K; Zintzaras E; Tzioufas AG
Clin Exp Rheumatol; 2010; 28(1):83-6. PubMed ID: 20346244
[TBL] [Abstract][Full Text] [Related]
30. Cumulative immunosuppressant exposure is associated with diversified cancer risk among 14 832 patients with systemic lupus erythematosus: a nested case-control study.
Hsu CY; Lin MS; Su YJ; Cheng TT; Lin YS; Chen YC; Chiu WC; Chen TH
Rheumatology (Oxford); 2017 Apr; 56(4):620-628. PubMed ID: 28039419
[TBL] [Abstract][Full Text] [Related]
31. Infectious complications in SLE after immunosuppressive therapies.
Kang I; Park SH
Curr Opin Rheumatol; 2003 Sep; 15(5):528-34. PubMed ID: 12960476
[TBL] [Abstract][Full Text] [Related]
32. Severe infections in systemic lupus erythematosus: disease pattern and predictors of infection-related mortality.
Teh CL; Wan SA; Ling GR
Clin Rheumatol; 2018 Aug; 37(8):2081-2086. PubMed ID: 29667100
[TBL] [Abstract][Full Text] [Related]
33. Severe pneumonia in Chinese patients with systemic lupus erythematosus.
Peng L; Wang Y; Zhao L; Chen T; Huang A
Lupus; 2020 Jun; 29(7):735-742. PubMed ID: 32403979
[TBL] [Abstract][Full Text] [Related]
34. [Herpes-zoster virus infection in patients with systemic lupus erythematosus].
Moga I; Formiga F; Canet R; Pac M; Mitjavila F; Pujol R
Rev Clin Esp; 1995 Aug; 195(8):530-3. PubMed ID: 7569198
[TBL] [Abstract][Full Text] [Related]
35. Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy.
Opastirakul S; Chartapisak W
Pediatr Nephrol; 2005 Dec; 20(12):1750-5. PubMed ID: 16133037
[TBL] [Abstract][Full Text] [Related]
36. Association Between Mycophenolate Mofetil Use and Subsequent Infections Among Hospitalized Patients with Systemic Lupus Erythematosus: A Nested Case-Control Study.
Guo Q; Zhang X; Sun S; Tang X; Shen W; Liang J; Yao G; Geng L; Ding S; Chen H; Wang H; Hua B; Zhang H; Wang D; Feng X; Sun L; Jin Z
Rheumatol Ther; 2023 Dec; 10(6):1535-1554. PubMed ID: 37742321
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus.
Fassbinder T; Saunders U; Mickholz E; Jung E; Becker H; Schlüter B; Jacobi AM
Arthritis Res Ther; 2015 Apr; 17(1):92. PubMed ID: 25890338
[TBL] [Abstract][Full Text] [Related]
38. Clinical and genetic risk factors of herpes zoster in patients with systemic lupus erythematosus.
Kang TY; Lee HS; Kim TH; Jun JB; Yoo DH
Rheumatol Int; 2005 Mar; 25(2):97-102. PubMed ID: 14593495
[TBL] [Abstract][Full Text] [Related]
39. A survival case of visceral disseminated varicella zoster virus infection in a patient with systemic lupus erythematosus.
Ishino Y; Fukasawa H; Kitamoto S; Nakagami D; Kaneko M; Yasuda H; Furuya R
BMC Nephrol; 2023 Jun; 24(1):164. PubMed ID: 37291486
[TBL] [Abstract][Full Text] [Related]
40. Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort.
Mok CC; Tse SM; Chan KL; Ho LY
Lupus; 2018 Apr; 27(5):722-727. PubMed ID: 29087260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
